-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$7.53 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$10.31 M
Mineralys Therapeutics, Inc. Insider Transactions
Mineralys Therapeutics, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Slingsby Brian Taylor
Director, 10 percent owner: |
Sell | 550,000 @ $13.05 | $7.18 M | 8,644,579 | 07/24/2024 | 07/26/2024 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 525 @ $15.00 | $7,876 | 102,873 | 07/16/2024 | 07/18/2024 | |
Levy Adam Scott
CFO and Secretary |
Sell | 10,757 @ $13.14 | $141,394 | 247,611 | 07/11/2024 | 07/12/2024 | |
Congleton Jon
CEO |
Sell | 15,746 @ $13.34 | $210,075 | 911,212 | 07/11/2024 | 07/12/2024 | |
Congleton Jon
CEO |
Sell | 14,940 @ $11.73 | $175,237 | 926,958 | 06/20/2024 | 06/20/2024 | |
Congleton Jon
CEO |
Sell | 16,607 @ $11.99 | $199,073 | 941,898 | 06/18/2024 | 06/20/2024 | |
Congleton Jon
CEO |
Sell | 17,766 @ $12.25 | $217,712 | 958,505 | 06/17/2024 | 06/20/2024 | |
Congleton Jon
CEO |
Sell | 16,229 @ $12.52 | $203,163 | 976,271 | 06/14/2024 | 06/14/2024 | |
Congleton Jon
CEO |
Sell | 39,961 @ $12.74 | $509,027 | 992,500 | 06/13/2024 | 06/14/2024 | |
Congleton Jon
CEO |
Sell | 16,607 @ $12.77 | $212,013 | 1,032,461 | 06/12/2024 | 06/14/2024 | |
Levy Adam Scott
CFO and Secretary |
Sell | 96,815 @ $12.94 | $1.25 M | 255,462 | 06/11/2024 | 06/13/2024 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 100 @ $15.00 | $1,500 | 66,997 | 05/09/2024 | 05/10/2024 | |
Samsara BioCapital GP, LLC
10 percent owner |
Buy | 555,555 @ $13.50 | $7.50 M | 5,074,916 | 02/12/2024 | 02/14/2024 | |
Congleton Jon
CEO |
Buy | 4,250 @ $5.97 | $25,356 | 1,049,068 | 11/22/2023 | 11/27/2023 | |
Congleton Jon
CEO |
Buy | 2,250 @ $12.08 | $27,180 | 1,044,818 | 09/06/2023 | 09/08/2023 | |
Congleton Jon
CEO |
Buy | 2,250 @ $12.10 | $27,225 | 1,042,568 | 08/17/2023 | 08/21/2023 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 76,182 @ $12.81 | $975,891 | 0 | 08/11/2023 | 08/11/2023 | |
Congleton Jon
CEO |
Buy | 2,000 @ $12.89 | $25,780 | 1,040,318 | 08/11/2023 | 08/11/2023 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 74,625 @ $13.16 | $982,065 | 0 | 08/10/2023 | 08/11/2023 | |
HBM Healthcare Investments (Cayman) Ltd.
10 percent owner |
Buy | 312,500 @ $16.00 | $5.00 M | 3,218,106 | 02/14/2023 | 02/16/2023 |
Mineralys Therapeutics, Inc. Frequently Asked Questions
-
Who is on Mineralys Therapeutics, Inc.'s Insider Roster?
The list of insiders at Mineralys Therapeutics, Inc. includes Congleton Jon, Samsara BioCapital GP, LLC, Rodman David Malcom, Levy Adam Scott, Slingsby Brian Taylor.
-
How much insider selling is happening at Mineralys Therapeutics, Inc.?
Insiders have sold a total of 796,053 Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 10.31 M sold.
-
Which Mineralys Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Mineralys Therapeutics, Inc. shares in the last 12 months: Rodman David Malcom ($9,376), Levy Adam Scott ($1.39 M), Congleton Jon ($1.73 M), Slingsby Brian Taylor ($7.18 M),
-
How much insider buying is happening at Mineralys Therapeutics, Inc.?
Insiders have purchased a total of 559,805 Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 7.53 M sold.
-
Which Mineralys Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Mineralys Therapeutics, Inc. shares in the last 12 months: Congleton Jon ($25,356), Samsara BioCapital GP, LLC ($7.50 M),